Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page
- Check3 days agoChange DetectedSchizophrenia is removed from the study context and the related topics section no longer lists MedlinePlus Genetics. This changes how the study's focus is presented and what background resources are linked on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2 label on the page, signaling a new version of the page/document. This reflects version control activity rather than a substantive change to the study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdded related topics: Schizophrenia and MedlinePlus Genetics. Updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoved the Schizophrenia topic and the MedlinePlus Genetics related topic from the page.SummaryDifference0.1%

- Check53 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0, with no visible changes to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics, and updated the site revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.